Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and fiscal year 2021. For the first half, the company expects net sales of ¥70,000 million, operating income of ¥2,850 million and net income attributable to owners of parent of ¥2,000 million or ¥131.78 per share. For the year ending June 20, 2021, the company expects net sales of ¥145,000 million, operating income of ¥5,800 million and net income attributable to owners of parent of ¥4,100 million or ¥270.14 per share.